A possible approach to the treatment of progressive multifocal leukoencephalopathy (PML) — a rare and often fatal viral disease of the brain that occurs in immunosuppressed patients and has no current ...

NEW YORK, Sept. 25, 2018 /PRNewswire/ -- This Persistence Market Research (PMR) report examines the 'Global Progressive Multifocal Leukoencephalopathy Treatment Market' for the period 2018–2026. The ...

The global progressive multifocal leukoencephalopathy treatment market is likely to reach a valuation of US$ 150.5 Mn by 2026 by the end of 2026 Progressive multifocal leukoencephalopathy (PML) is a ...

Paris, France, July 10, 2012 - Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that the European Commission has ...

Patients with progressive multifocal leukoencephalopathy (PML), which is caused by the JC virus, can be successfully treated using cryopreserved BK-virus-specific T cells, new research suggests.

We describe a patient with progressive multifocal leukoencephalopathy (PML) who had clinical stabilization and no progression as assessed on magnetic resonance imaging (MRI) as a result of treatment ...

Medicines that reshape or tamp down immune responses may be life-changing for patients with cancer and autoimmune disorders, but in some cases they can awaken a dormant virus and unleash a deadly ...

Preparations containing various mixtures of fumaric acid esters are prescribed for psoriasis in several countries, in many cases for off-label use, and are regarded as safe. 1 One such preparation is ...

A recent study in The FASEB Journal identifies a new mechanism of pancreatic tumors' resistance to chemotherapeutic treatment. The mechanism involves the loss of function of promyelocytic leukemia ...

Paris, October 24, 2012 - Cytheris SA, a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that the US Food and Drug Administration (FDA) has ...